| 标题 |
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:L. Carey; D. Berry; C. Cirrincione; W. Barry; B. Pitcher; et al 出版日期:2016-09-19 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)